Preview

Pediatric pharmacology

Advanced search

NEW PREVENTION OPPORTUNITIES OF INFECTIOUS DISEASES. VACCINATION AGAINST ROTAVIRUS

https://doi.org/10.15690/pf.v10i6.890

Abstract

The article covers the problem of the burden of rotavirus disease. Rotavirus infection is the leading cause of mortality among children under 5 years of age and is a major problem for a public healthcare. The world is actively engaged in the prevention of rotavirus infection since 2005. There is a lot of data on the efficacy and safety of this vaccine. Different foreign investigations have shown the herd immunity of the vaccine. The authors present data about the effectiveness and safety of vaccines, established during clinical studies of the foreign scientists.


About the Authors

T. A. Grechukha
Scientific Center of Children’s Health, Moscow
Russian Federation
MD, senior research scientist, immunologist of the vaccinal prevention department for children with health deviations of the SCCH


N. E. Tkachenko
Scientific Center of Children’s Health, Moscow, Russian Federation


L. S. Namazova-Baranova
T.A. Grechukha1, N.E. Tkachenko1, L.S. Namazova-Baranova1, 2, 3 Scientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation Pirogov Russian National Medical Research University, Moscow


References

1. Carl D. Kirkwood, Karen Boniface, Graeme L. Barnes. Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix and RotaTeq, into the National Immunization Program of Australia. The Pediatric Infectious Disease Journal. 2011; 30 (1): 48–53.

2. Podkolzin A. T., Petukhov D. N., Veselova O. A. Publication of reference center for pathogens intestinal infections monitoring. Available at: http://www.epid-oki.ru

3. Florence T. Wang, Christopher T. Mast, Roberta J. Glass et al. Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States. Pediatrics. 2010: 208–213.

4. Rezolyutsiya uchastnikov soveta ekspertov po teme «Bremya rotavirusnoi infektsii v Rossiiskoi Federatsii i potrebnost' v spetsificheskoi profilaktike» [Resolution of the Board Members of Experts on "The Burden of Rotavirus Infection in the Russian Federation and the Need for Specific Prevention"]. Moscow, 2011.

5. Kostinov M. P. Zhurnal mikrobiologii i epidemiologii = Journal of microbiology and epidemiology. 2012; 3.

6. Roger I. Glass, Manish Patel, Umesh Parashar. Lessons From the US Rotavirus Vaccination Program. JAMA. October 19, 2011; 306 (15): 1701–1702.

7. Mary A. Staat, Daniel C. Payne et al. Effectiveness of Pentavalent Rotavirus Vaccine Against Severe Disease. Pediatrics. 2011: 267–274.

8. Ben A. Lopman, Daniel C. Payne, Jacqueline E. Tate et al. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Current Opinion in Virology. 2012; 2: 434–442.

9. Stephen B. Lambert, Cassandra E. Faux et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. MJA. 2009; 191: 157–160.

10. Grechukha T. A., Galitskaya M. G., Gaivoronskaya A. G., Namazova-Baranova L. S. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2013; 10 (5): 14–17.

11. Available at: http://www.rotateq.com

12. Evan J. Anderson, Deanna B. Shippee et al. Indirect Protection of Adults From Rotavirus by Pediatric Rotavirus Vaccination. Clinical Infectious Diseases. 2013; 56 (6): 755–760.

13. Ben A. Lopman, Aaron T. Curns, Catherine Yen et al. Infant Rotavirus Vaccination May Provide Indirect Protection to Older Children and Adults in the United States. The Journal of Infectious Diseases. 2011; 204: 980–986.

14. Available at: http://sites.path.org/rotavirusvaccine/rotavirus-advocacyand-communications-toolkit/country-introduction-maps-and-list/

15. Federico Martinon-Torres, Marta Bouzon Alejandro, Lorenzo Redondo Collaz et al. Effectiveness of rotavirus vaccination in Spain. Human Vaccines. July 2011; 7 (7): 757–761.

16. Hemming M., Vesikari T. Genetic diversity of G1P [8] rotavirus VP 7 and VP8 antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq. vaccine. Infection, Genetics and Evolution. 2013; 19: 51–58.

17. Manish M. Patel, Duncan Steele et al. Real-world Impact of Rotavirus Vaccination. The Pediatric Infectious Disease Journal. January 2011; 30 (1).


Review

For citations:


Grechukha T.A., Tkachenko N.E., Namazova-Baranova L.S. NEW PREVENTION OPPORTUNITIES OF INFECTIOUS DISEASES. VACCINATION AGAINST ROTAVIRUS. Pediatric pharmacology. 2013;10(6):6-9. (In Russ.) https://doi.org/10.15690/pf.v10i6.890

Views: 874


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)